The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2016;9(4): 11‑16

Read: 672 times

To cite this article:

. Evidence-based Cardiology. 2016;9(4):11‑16. (In Russ.)

References:

  1. Verdecchia P., Porcellati C., Schillaci G., et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793—801.
  2. Sega R., Facchetti R., Bombelli M., et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777—1783.
  3. Staessen J.A., Thijs L., Fagard R., et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539—546.
  4. Dolan E., Stanton A., Thijs L., et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005;46:156—161.
  5. Minutolo R., Gabbai F.B., Agarwal R., et al. Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am J Kidney Dis 2014;64:744—752.
  6. Hansen T.W., Li Y., Boggia J., et al. Predictive role of the nighttime blood pressure. Hypertension 2011;57:3—10.
  7. Mancia G., Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004;22:435—445.
  8. Mancia G., Omboni S., Parati G., et al. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001;19:1755—1763.
  9. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103—2116.
  10. Ambrosius W.T., Sink K.M., Foy C.G., et al; SPRINT Study Research Group. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials 2014;11:532—546.
  11. O’Brien E., Asmar R., Beilin L., et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003;21:821—848.
  12. O’Brien E., Coats A., Owens P., et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ 2000;320:1128—1134.
  13. Drawz P.E., Alper A.B., Anderson A.H., et al; Chronic Renal Insufficiency Cohort Study Investigators. Masked hypertension and elevated night- time blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol 2016;11:642—652.
  14. Gabbai F.B., Rahman M., Hu B., et al; African American Study of Kidney Disease and Hypertension (AASK) Study Group. Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 2012;7:1770—1776.
  15. Parati G., Stergiou G., O’Brien E., et al; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359—1366.
  16. Lurbe E., Redon J., Kesani A., et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002;347:797—805.
  17. Hansen T.W., Thijs L., Li Y., et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 2010;55:1049—1057.
  18. Mena L., Pintos S., Queipo N.V., et al. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005;23:505—511.
  19. Bland J.M., Altman D.G. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085—1087.
  20. Esler M.D., Krum H., Sobotka P.A., et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903—1909.
  21. Muntner P., Whittle J., Lynch A.I., et al. Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med. 2015;163:329—338.
  22. Cuspidi C., Facchetti R., Bombelli M., et al. Nighttime blood pressure and new-onset left ventricular hypertrophy: findings from the Pamela population. Hypertension 2013;62:78—84.
  23. Perez-Lloret S., Toblli J.E., Cardinali D.P., et al. Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping. Int J Cardiol 2008;127:387—389.
  24. Piper M.A., Evans C.V., Burda B.U., et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162:192—204.
  25. Siu A.L.; US Preventive Services Task Force. Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 2015;163:778—786.
  26. Bobrie G., Chatellier G., Genes N., et al. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342—1349.
  27. Myers M.G., Godwin M., Dawes M., et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011;342:d286.
  28. Muxfeldt E.S., Fiszman R., de Souza F., et al. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension. Hypertension 2012;59:384—389.
  29. Minutolo R., Gabbai F.B., Borrelli S., et al. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Am J Kidney Dis 2007;50:908—917.
  30. Hermida R.C., Ayala D.E., Mojon A., Fernandez J.R. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int 2010;27:1629—1651.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.